China accuses former GSK head of bribing doctors
Updated: 2014-05-14 15:39
Another way to bribe doctors is to cover the expenses of attending medical seminars.
Zhang Guowei, a key suspect who was vice president and human resources director of GSK China, told Xinhua that the focus on sales growth led to the bribery.
"The global headquarters imposed high sales growth targets. When Reilly took over the post, the company's strategy shifted from profit-oriented to sales-oriented. The sales target in China was raised every year to compensate the reduction in US and European markets," Zhang said.
According to Guo Jianhua, a human resources manager also involved in the case, the company's sales force increased from about 1,000 in 2008 to 5,500 today.
Police found that the company forced its sales team to bribe to achieve their soaring sales targets.
Liang Hong who was the company's vice president and operations manager, confirmed that those who met sales targets received big bonuses, promotions and overseas vacations while those who failed were demoted or fired.
In a statement to police, Liang said every representative was allowed to spend 3,000 to 5,000 yuan on kickbacks to doctors. "If this was not enough, they could apply for more. For hepatitis medicines, the kickback can account for five to eight percent of the drug's price," he said, but for other drugs might be as much as 30 percent and total hundreds of million yuan.
GSK China's revenue in China increased from about 3.9 billion yuan in 2009 to 6.9 billion yuan in 2012.
- China hosts major Asia security conference
- Xi vows support for Afghanistan reconstruction
- Security summit to help build mutual trust
- Russian president arrives for state visit
- China suspends cyber working group activities with US to protest cyber theft indictment
- China publishes latest data of US cyber attack